Food and drug administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme

Clinical Cancer Research

Volumn 11, Issue 19 I, 2005, Pages 6767-6771

  Cohen, Martin H ^a   Johnson, John R ^a   Pazdur, Richard ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CORTICOSTEROID; LOMUSTINE; PROCARBAZINE; SEROTONIN 3 ANTAGONIST; TEMOZOLOMIDE; VINCRISTINE;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANOREXIA; ARTHRALGIA; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONVULSION; COUGHING; DIARRHEA; DISEASE COURSE; DIZZINESS; DRUG APPROVAL; DRUG HYPERSENSITIVITY; DRY SKIN; DYSPNEA; ERYTHEMA; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; GLIOBLASTOMA; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MULTICENTER STUDY; NAUSEA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RADIATION INJURY; RASH; STOMATITIS; TASTE DISORDER; THROMBOCYTOPENIA; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG APPROVAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS; PNEUMOCYSTIS INFECTIONS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RADIOTHERAPY; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 26444610107     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0722     Document Type: Article

References (13)

1. Newlands ES, Stevens MF, Wedge SR, et al. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997;23:35-61.
2. 6-benzylguanine. J Med Chem 2004;47:6875-83.
3. Ostermann S, Csajka C, Buclin T, et al. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 2004;10:3728-36.
4. Nagasubramanian R, Dolan ME. Temozolomide: realizing the promise and potential. Curr Opin Oncol 2003;15:412-8.
5. Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res 2000; 6:2585-97.
6. Yung WK, Prados MD, Yaya-Tur R, et al. Multicenter phase Il trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999;17:2762-71.
7. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
8. 21 CFR Sect. 314.106 and 21 CFR Sect. 312.120. 2004.
9. Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-8.
10. Fine HA, Dear KB, Loeffler JS, et al Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
11. Athanassiou H, Synodinou M, Maragoudakis E, et al. Temozolomide combined with radiotherapy versus radiotherapy alone in newly diagnosed glioblastoma multiforme: a randomized phase III study [abstract]. Eur J Cancer 2003;1:S95.
12. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002;20:1375-82.
13. Lanzetta G, Campanella C, Rozzi A, et al. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 2003;23:5159-64.